Why the study?
Fulminant myocarditis is a distinct and rare form of myocarditis, prompting investigation into serum hsa-miR-21 expression and its clinical value in pediatric patients.
Does serum hsa-miR-21 expression predict poor prognosis in pediatric patients with fulminant myocarditis?
Does serum hsa-miR-21 expression predict poor prognosis in pediatric patients with fulminant myocarditis?
Serum hsa-miR-21 is upregulated in pediatric fulminant myocarditis and serves as an independent risk factor for poor prognosis, though its predictive accuracy is limited.
Answers are grounded in this paper and cite their sources.
hsa-miR-21 levels were associated with poor prognosis in pediatric FM; leaves open its value as a biomarker pending validation.
OBJECTIVE: Fulminant myocarditis (FM) is a distinct and rare form of myocarditis. This study probed hsa-miR-21 expression in FM pediatric patients and its clinical value. METHODS: This study enrolled 88 FM pediatric patients and 90 healthy children (normal controls), with serum sample hsa-miR-21 levels measured by RT-qPCR. FM children were categorized into the good and poor prognosis groups. Correlations of hsa-miR-21 expression with myocardial injury markers [cardiac troponin I (cTnI), creatine kinase isoenzyme (CK-MB)], and independent risk factors and predictive value of hsa-miR-21 expression for FM patients' poor prognoses were analyzed by Pearson's, logistic regression, and receiver operating characteristic (ROC) curve analyses. RESULTS: Serum hsa-miR-21 levels were elevated in FM children relative to the healthy controls and linked with poor prognoses. hsa-miR-21 levels positively correlated with myoglobin (MYO), B-type natriuretic peptide (BNP), cTnI, and CK-MB levels. Elevated hsa-miR-21, CK-MB, left ventricular ejection fraction, C-reactive protein, lactate dehydrogenase, and lactate were independent risk factors for FM children's poor prognoses. Serum hsa-miR-21 levels yielded an area under the ROC curve of 0.790 in predicting FM pediatric patients' poor prognoses (58.1 % sensitivity, 87.7 % specificity), with positive and negative predictive values of 74.07 % and 81.97 %, respectively, demonstrating that hsa-miR-21 aided in predicting FM pediatric patients' poor prognoses to some extent. CONCLUSION: Serum hsa-miR-21 was up-regulated in FM pediatric patients, and positively correlated with MYO, BNP, cTnI, and CK-MB. hsa-miR-21 expression was an independent risk factor for FM pediatric patients' poor prognosis, and predicted prognoses to some extent; however, the diagnostic accuracy was limited.
No takes yet. Share an insight, caveat, or question.
Jingmin Sun (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: